Prosthetic mesh placement for the prevention of parastomal herniation

被引:56
|
作者
Jones, Huw G. [1 ]
Rees, Michael [2 ]
Aboumarzouk, Omar M. [3 ]
Brown, Joshua [4 ]
Cragg, James [2 ]
Billings, Peter [2 ]
Carter, Ben [5 ]
Chandran, Palanichamy [2 ]
机构
[1] ABM Univ NHS Trust, Singleton Hosp, Dept Colorectal Surg, Sketty Lane, Swansea SA2 8QA, W Glam, Wales
[2] BCUHB, Wrexham Maelor Hosp, Dept Gen Surg, Wrexham, Wales
[3] NHS Greater Glasgow & Clyde, Dept Urol, Glasgow, Lanark, Scotland
[4] Royal Gwent Hosp, Dept Gen Surg, Newport, Shrops, England
[5] Kings Coll London, Biostat & Hlth Informat, Inst Psychiat Psychol & Neurosci, London, England
关键词
PROPHYLACTIC MESH; POLYPROPYLENE MESH; END-COLOSTOMY; STOMA FORMATION; REPAIR; COMPLICATIONS; METAANALYSIS; TRIAL; MULTICENTER; MANAGEMENT;
D O I
10.1002/14651858.CD008905.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Parastomal herniation is a common problem following formation of a stoma after both elective and emergency abdominal surgery. Symptomatic hernias give rise to a significant amount of patient morbidity, and in some cases mortality, and therefore may necessitate surgical treatment to repair the hernial defect and/or re-site the stoma. In an effort to reduce this complication, recent research has focused on the application of a synthetic or biological mesh, inserted during stoma formation to help strengthen the abdominal wall. Objectives The primary objective was to evaluate whether mesh reinforcement during stoma formation reduces the incidence of parastomal herniation. Secondary objectives included the safety or potential harms or both of mesh placement in terms of stoma-related infections, mesh-related infections, patient-reported symptoms/postoperative quality of life, and re-hospitalisation/ambulatory visits. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL; the Cochrane Library 2018, Issue 1), Ovid MEDLINE (1970 to 11 January 2018), Ovid Embase (1974 to 11 January 2018), and Science Citation Index Expanded (1970 to 11 January 2018). To identify ongoing studies, we also searched the metaRegister of Controlled Trials (mRCT) on 11 January 2018. Selection criteria We considered for inclusion all randomised controlled trials (RCTs) of prosthetic mesh (including biological/composite mesh) placement versus a control group (no mesh) for the prevention of parastomal hernia. Data collection and analysis Two review authors independently assessed the studies identified by the literature search for potential eligibility. We obtained the full articles for all studies that potentially met the inclusion criteria and included all those that met the criteria. Any differences in opinion between review authors were resolved by consensus. We pooled study data into a meta-analysis. We assessed heterogeneity by calculation of I-2 and expressed results for each variable as a risk ratio (RR) with corresponding 95% confidence intervals (CI). We expressed continous outcomes as mean difference (MD) with corresponding 95% CIs. Main results We included 10 RCTs involving a total of 844 participants. The primary outcome was overall incidence of parastomal herniation. Secondary outcomes were rate of reoperation at 12 months, operative time, postoperative length of hospital stay, stoma-related infections, mesh-related infections, quality of life, and rehospitalisation rate. We judged the risk of bias across all domains to be low in six trials. We judged four trials to have an overall high risk of bias. The overall incidence of parastomal hernia was less in participants receiving a prophylactic mesh compared to those who had a standard ostomy formation (RR 0.53, 95% CI 0.43 to 0.66; 10 studies, 771 participants; I-2 = 69%; low-quality evidence). In absolute numbers, the incidence of parastomal hernia was 22 per 100 participants (18 to 27) receiving prophylactic mesh compared to 41 per 100 participants having a standard ostomy formation. There were no differences in the need for reoperation (RR 0.90, 95% CI 0.50 to 1.64; 9 studies, 757 participants; I-2 = 0%; low-quality evidence); operative time (MD -6.50 (min), 95% CI -18.24 to 5.24; 6 studies, 671 participants; low-quality evidence); postoperative length of hospital stay (MD -0.95 (days), 95% CI -2.03 to 0.70; 4 studies, 500 participants; moderate-quality evidence); or stoma-related infections (RR 0.89, 95% CI 0.32 to 2.50; 6 studies, 472 participants; I-2 = 0%; low-quality evidence) between the two groups. We were unable to analyse mesh-related infections, quality of life, and rehospitalisation rate due to sparse data or because the outcome was not reported in the included studies. Authors' conclusions This Cochrane Review included 10 RCTs with a total of 844 participants. The review demonstrated a reduction in the incidence of parastomal hernia in people who had a prophylactic synthetic mesh placed at the time of the index operation compared to a standard ostomy formation. However, our confidence in this estimate is low due to the presence of a large degree of clinical heterogeneity, as well as high variability in follow-up duration and technique of parastomal herniation detection. We found the rate of stoma-related infection to be similar in both the intervention and control groups.
引用
收藏
页数:69
相关论文
共 50 条
  • [21] Comment to: Prophylactic retromuscular mesh placement for parastomal hernia prevention. Author’s reply
    J. Frigault
    S. Lemieux
    S. Drolet
    Hernia, 2022, 26 : 673 - 674
  • [22] Validation of Urostomy Parastomal Herniation Incisional Prevention Strategies
    Kanabolo, Diboro L.
    Maxwell, Adam D.
    Kumar, Yashwanth Nanda
    Schade, George R.
    UROLOGY, 2024, 185 : 131 - 136
  • [23] Prophylactic mesh placement for the PREvention of paraSTOmal hernias: The PRESTO systematic review and meta-analysis
    Pianka, Frank
    Probst, Pascal
    Keller, Anne-Valerie
    Saure, Daniel
    Grummich, Kathrin
    Buechler, Markus W.
    Diener, Markus K.
    PLOS ONE, 2017, 12 (02):
  • [24] Response to the Comment on "Meta-Analysis and Systematic Review of the Use of a Prosthetic Mesh for Prevention of Parastomal Hernia''
    Prudhomme, Michel
    Fabbro-Peray, Pascale
    Occean, Bob V.
    Bertrand, Martin M.
    ANNALS OF SURGERY, 2021, 274 (06) : E912 - E913
  • [25] ASSESSMENT OF UROSTOMY PARASTOMAL HERNIATION FORCES AND PREVENTION STRATEGIES
    Kanabolo, Diboro
    Maxwell, Adam
    Kumar, Yashwanth Nanda
    Kuznetsova, Ekaterina
    Schade, George
    JOURNAL OF UROLOGY, 2023, 209 : E890 - E891
  • [26] Prophylactic Mesh Placement in Preventing Parastomal Hernia Formation
    Nnaji, M.
    Adedeji, O.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 179 - 179
  • [27] Prevention of parastomal hernia with a preperitoneal polypropelene mesh
    Valdes-Hernandez, Javier
    Diaz Milanes, Juan Antonio
    Capitan Morales, Luis Cristobal
    del Rio la Fuente, Francisco Javier
    Torres Arcos, Cristina
    Canete Gomez, Jesus
    Oliva Mompean, Fernando
    Padillo Ruiz, Javier
    CIRUGIA ESPANOLA, 2015, 93 (07): : 455 - 459
  • [28] Prevention of a parastomal hernia by biological mesh reinforcement
    Fortelny, Rene H.
    Hofmann, Anna
    May, Christopher
    Koeckerling, Ferdinand
    FRONTIERS IN SURGERY, 2015, 2
  • [29] Comment to: Prophylactic retromuscular mesh placement for parastomal hernia prevention. Author's reply COMMENT
    Frigault, J.
    Lemieux, S.
    Drolet, S.
    HERNIA, 2022, 26 (02) : 673 - 674
  • [30] Prophylactic retromuscular mesh placement for parastomal hernia prevention: a retrospective cohort study of permanent colostomies and ileostomies
    Jonathan Frigault
    Simon Lemieux
    Dominic Breton
    Philippe Bouchard
    Alexandre Bouchard
    Roger C. Grégoire
    François Letarte
    Gilles Bouchard
    Vincent Boun
    Katia Massé
    Sébastien Drolet
    Hernia, 2022, 26 : 495 - 506